Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 2.63
Key Takeaways
Risk factor
Strong & resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Qingdao Haier Biomedical Co., Ltd. engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples worldwide. The company offers cryo, ULT, biomedical, spark free, vaccine, and plasma freezers; laboratory, pharmacy, blood bank, and vaccine refrigerators; blood/fluid warming cabinets; backup systems; consumables; cold/freezer rooms; vaccine safety solutions; and plasma apheresis...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Data is available to registered users only
Buy
Sell